Matt Viaches

Matt Viaches is an accomplished finance professional with extensive experience in the pharmaceutical industry. Currently serving as Executive Director of Finance for R&D and CFIB at Elanco since November 2018, Matt previously held various finance roles at Eli Lilly and Company from July 2011 to November 2018, including Finance Director for R&D and Financial Consultant for Diabetes. Earlier career experiences include a position as a Finance Director and Financial Consultant at Eli Lilly, as well as a brief role as an MBA Marketing Intern at Medtronic. Matt's educational background includes an MBA from Stanford University Graduate School of Business and dual BBA degrees from the University of Michigan - Stephen M. Ross School of Business.